Microbot Financial Statements From 2010 to 2025

MBOT Stock  USD 2.55  0.02  0.79%   
Analyzing historical trends in various income statement and balance sheet accounts from Microbot Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Microbot Medical's valuation are summarized below:
Market Capitalization
102 M
Earnings Share
(0.64)
There are currently one hundred twenty fundamental ratios for Microbot Medical that can be evaluated and compared over time across peers in the industry. All traders should check Microbot Medical's last-minute fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 16.6 M in 2025. Enterprise Value is likely to drop to about 13.8 M in 2025

Microbot Medical Total Revenue

0.0

Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.5 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 79.82 or PTB Ratio of 5.21. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
Build AI portfolio with Microbot Stock
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Microbot Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.7 MM18.6 M
Slightly volatile
Short and Long Term Debt Total105.5 K111 K2.8 M
Slightly volatile
Other Current Liabilities3.4 M2.2 M3.3 M
Slightly volatile
Total Current Liabilities4.7 M2.5 M4.4 M
Slightly volatile
Property Plant And Equipment Net201.4 K212 K1.6 M
Slightly volatile
Accounts Payable156.8 K165 K284.1 K
Slightly volatile
CashM3.1 M12.2 M
Slightly volatile
Non Current Assets Total201.4 K212 K2.7 M
Slightly volatile
Cash And Short Term Investments5.2 M5.5 M14.8 M
Slightly volatile
Net Receivables367.6 K300 K292.4 K
Pretty Stable
Common Stock Shares Outstanding16.4 M15.6 M5.4 M
Slightly volatile
Liabilities And Stockholders Equity5.7 MM18.6 M
Slightly volatile
Non Current Liabilities Total38.9 K41 K4.3 M
Slightly volatile
Other Current Assets46.5 K49 K785 K
Pretty Stable
Other Stockholder Equity99 M94.3 M166.1 M
Slightly volatile
Total Liabilities2.4 M2.5 M8.5 M
Slightly volatile
Total Current Assets5.5 M5.8 M16 M
Slightly volatile
Short Term Debt66.5 K70 K772.3 K
Slightly volatile
Property Plant And Equipment Gross756.2 K796 K2.3 M
Slightly volatile
Common Stock185.2 K195 K344.9 K
Slightly volatile
Common Stock Total Equity61.5664.8322.6 K
Slightly volatile
Current Deferred Revenue1.2 M1.2 M1.4 M
Slightly volatile
Long Term Debt Total83 K87.4 K1.9 M
Slightly volatile
Capital Surpluse58.6 M61.7 M180.1 M
Slightly volatile
Deferred Long Term Liabilities6.8 K7.2 K513.6 K
Slightly volatile
Non Current Liabilities Other535.2 K563.4 K2.4 M
Slightly volatile
Property Plant Equipment1.2 M650.7 K1.4 M
Slightly volatile
Capital Lease Obligations105.5 K111 K382.1 K
Slightly volatile
Other Liabilities6.8 K7.2 K1.1 M
Slightly volatile
Short and Long Term Debt65 K68.4 K1.5 M
Slightly volatile
Warrants400 K450 K490.6 K
Slightly volatile
Net Invested Capital3.4 M3.5 M10.6 M
Very volatile
Net Working Capital3.2 M3.4 M10.7 M
Pretty Stable
Capital Stock100.6 K195 K61.8 K
Slightly volatile

Microbot Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization86.5 K91 K424.4 K
Slightly volatile
Other Operating Expenses16.1 M11.3 M14.2 M
Pretty Stable
Research Development8.9 M6.5 M8.6 M
Slightly volatile
Selling General Administrative4.7 MM4.6 M
Very volatile
Selling And Marketing Expenses182192264.4 M
Slightly volatile
Non Recurring524 K589.5 K642.7 K
Slightly volatile
Interest Income256 K243.8 K68.3 K
Slightly volatile
Reconciled Depreciation82.5 K91 K51.8 K
Slightly volatile

Microbot Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2.4 M2.5 M12 M
Pretty Stable
Depreciation86.5 K91 K355.1 K
Slightly volatile
Capital Expenditures23.8 K25 K469 K
Slightly volatile
End Period Cash FlowM3.2 M12.7 M
Slightly volatile
Stock Based Compensation1.3 M1.3 M79.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio302383299
Slightly volatile
Dividend Yield79.8284.0293.2869
Slightly volatile
Days Sales Outstanding77.3581.4296.5469
Slightly volatile
Average Payables708.7 K1.1 M856.4 K
Pretty Stable
Stock Based Compensation To Revenue2.932.312.2828
Slightly volatile
Capex To Depreciation0.260.27471.4487
Pretty Stable
Sales General And Administrative To Revenue0.670.710.5787
Slightly volatile
Average Inventory393.8 K443 K483 K
Slightly volatile
Research And Ddevelopement To Revenue6.016.337.1979
Slightly volatile
Capex To Revenue0.01460.01540.4165
Slightly volatile
Cash Per Share0.330.34962.7 K
Slightly volatile
Income Quality0.940.77140.7763
Very volatile
Intangibles To Total Assets0.06020.07830.0862
Pretty Stable
Net Debt To EBITDA0.250.26451.0808
Pretty Stable
Current Ratio2.252.36546.0748
Very volatile
Receivables Turnover4.414.643.8295
Slightly volatile
Graham Number0.190.220.2383
Slightly volatile
Capex Per Share0.00150.0016127
Slightly volatile
Average Receivables332.5 K454.8 K446.9 K
Slightly volatile
Revenue Per Share1.751.8499.4444
Slightly volatile
Interest Debt Per Share0.00670.0071268
Slightly volatile
Debt To Assets0.01750.01841.2931
Pretty Stable
Ebt Per Ebit0.540.98431.0239
Slightly volatile
Long Term Debt To Capitalization0.03670.03860.1689
Slightly volatile
Total Debt To Capitalization0.0290.03050.1691
Slightly volatile
Quick Ratio2.252.36546.0701
Very volatile
Cash Ratio1.21.26599.0619
Pretty Stable
Days Of Sales Outstanding77.3581.4296.5469
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.221.00281.0477
Very volatile
Fixed Asset Turnover2.912.772.2299
Slightly volatile
Debt Ratio0.01750.01841.2931
Pretty Stable
Price Sales Ratio302383299
Slightly volatile
Asset Turnover0.270.250.1683
Slightly volatile

Microbot Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap16.6 M17.5 M50 M
Pretty Stable

Microbot Fundamental Market Drivers

Cash And Short Term Investments5.5 M

Microbot Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
15th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.2 M1.2 M
Cost Of Revenue91 K86.5 K
Stock Based Compensation To Revenue 2.31  2.93 
Sales General And Administrative To Revenue 0.71  0.67 
Research And Ddevelopement To Revenue 6.33  6.01 
Capex To Revenue 0.02  0.01 
Revenue Per Share 1.84  1.75 
Ebit Per Revenue(7.04)(6.69)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.